Nalaganje...
Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer
PURPOSE: Standard treatment for cases of non-small cell lung cancer (NSCLC) exhibiting acquired drug resistance includes tumor rebiopsy, epidermal growth factor receptor (EGFR) mutation testing (e.g., for T790M mutations), and the subsequent administration of third-generation EGFR-tyrosine kinase in...
Shranjeno v:
| izdano v: | Yonsei Med J |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Yonsei University College of Medicine
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6536394/ https://ncbi.nlm.nih.gov/pubmed/31124335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2019.60.6.525 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|